Literature DB >> 19329616

Pseudoclavibacter soli sp. nov., a {beta}-glucosidase-producing bacterium.

Myung Kyum Kim1, Hee-Young Jung.   

Abstract

A Gram-positive, aerobic, rod-shaped and non-motile bacterium, designated strain KP02(T), was isolated from soil from a ginseng field in Daejeon, South Korea. On the basis of 16S rRNA gene sequence similarity, this strain was shown to be related to 'Pseudoclavibacter alba' NBRC 15616 (95.5 %), 'Pseudoclavibacter faecalis' NBRC 15706 (93.9 %), Pseudoclavibacter helvolus DSM 20419(T) (93.7 %) and 'Pseudoclavibacter bifida' IAM 14848 (93.0 %). Chemotaxonomic data revealed that strain KP02(T) possessed MK-9 and MK-8 as major menaquinones and anteiso-C(15 : 0), anteiso-C(17 : 0), iso-C(16 : 0) and C(16 : 0 )as predominant fatty acids. The genomic DNA G+C content of strain KP02(T) was 64.4 mol%. The physiological and biochemical tests suggested that strain KP02(T) represents a novel species. Based on these data, strain KP02(T) (=KCTC 19255(T)=JCM 15058(T)) should be classified as the type strain of a novel Pseudoclavibacter species, for which the name Pseudoclavibacter soli sp. nov. is proposed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329616     DOI: 10.1099/ijs.0.65627-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  5 in total

1.  First report of endocarditis caused by a Pseudoclavibacter species.

Authors:  Hélène Pailhoriès; Carole Lemarié; Catherine Quinqueneau; Matthieu Eveillard; Christophe Baufreton; Frédéric Rouleau; Chetaou Mahaza; Marie-Laure Joly-Guillou; Marie Kempf
Journal:  J Clin Microbiol       Date:  2014-07-02       Impact factor: 5.948

Review 2.  Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory.

Authors:  Deirdre L Church; Lorenzo Cerutti; Antoine Gürtler; Thomas Griener; Adrian Zelazny; Stefan Emler
Journal:  Clin Microbiol Rev       Date:  2020-09-09       Impact factor: 26.132

3.  First case of Pseudoclavibacter bifida bacteremia in an immunocompromised host with chronic obstructive pulmonary disease (COPD).

Authors:  Matthijs Oyaert; Thierry De Baere; Joke Breyne; Emmanuel De Laere; Stan Mariën; Peter Waets; Wim Laffut
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

4.  Description of Pseudoclavibacter triregionum sp. nov. from human blood and Pseudoclavibacter albus comb. nov., and revised classification of the genus Pseudoclavibacter: proposal of Caespitibacter gen. nov., with Caespitibacter soli comb. nov. and Caespitibacter caeni comb. nov.

Authors:  Peter Vandamme; Charlotte Peeters; Helena M B Seth-Smith; Hanna Schmid; Margo Cnockaert; Adrian Egli; Daniel Goldenberger
Journal:  Antonie Van Leeuwenhoek       Date:  2022-02-02       Impact factor: 2.271

5.  Pseudoclavibacter otitis media in a 3-year-old boy with pulmonary and spinal tuberculosis.

Authors:  Satja Issaranggoon Na Ayuthaya; Amornrut Leelaporn; Pattarachai Kiratisin; Peninnah Oberdorfer
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.